The genetics and pathology of oxidative phosphorylation
Related Experiment Video
Updated: Oct 7, 2026

Assessing Energy Substrate Oxidation In Vitro with 14CO2 Trapping
Published on: March 23, 2022
J Smeitink1, L van den Heuvel, S DiMauro
1Nijmegen Centre for Mitochondrial Disorders, Department of Paediatrics, University Medical Centre Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. j.smeitink@ckskg.azn.nl
Abstract:
The mitochondrial oxidative phosphorylation (OXPHOS) system is the final biochemical pathway in the production of ATP. The OXPHOS system consists of five multiprotein complexes, the individual subunits of which are encoded either by the mitochondrial or by the nuclear genome. Defects in the OXPHOS system result in devastating, mainly multisystem, diseases, and recent years have seen the description of the underlying genetic mutations in mitochondrial and nuclear genes. Advances in this arena have profited from progress in various genome projects, as well as improvements in our ability to create relevant animal models.
Insights
Mitochondrial oxidative phosphorylation (OXPHOS) defects cause severe diseases due to genetic mutations. Advances in genome projects and animal models aid in understanding these complex genetic disorders.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- The mitochondrial oxidative phosphorylation (OXPHOS) system generates ATP through five multiprotein complexes.
- Subunits of OXPHOS complexes are encoded by both mitochondrial and nuclear genomes.
- OXPHOS dysfunction leads to severe, often multisystem, diseases.
Purpose of the Study:
- To review recent advances in understanding genetic mutations causing OXPHOS diseases.
- To highlight the role of genome projects and animal models in this research.
Main Methods:
- Literature review of genetic studies on OXPHOS disorders.
- Analysis of progress in genome sequencing and functional genomics.
- Examination of the utility of animal models in disease research.
Main Results:
- Numerous genetic mutations in mitochondrial and nuclear genes underlying OXPHOS defects have been identified.
- Genome projects have accelerated the discovery of disease-causing mutations.
- Development of relevant animal models has improved the study of OXPHOS disease pathogenesis.
Conclusions:
- Understanding the genetic basis of OXPHOS diseases is rapidly advancing.
- Technological progress, particularly in genomics and model systems, is crucial for future discoveries in mitochondrial medicine.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex III and IV
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
Mitochondria
Other Glycolytic Pathways
Glycolysis

